Cinfa Biotech is the biosimilars company of Cinfa Group, a pharmaceutical leader in Spain with more than 50 years of experience, offering a broad portfolio of business lines. We develop, manufacture and commercialise high-quality biosimilars for oncology and inflammatory diseases.
With our headquarters in Pamplona, Spain and offices in Munich, Germany we are committed to highest European quality standards. This forms the basis for addressing the global biosimilars market.
We do our business on a fully integrated level. We cover the entire pharmaceutical value chain from the manufacturing process development to clinical studies; and from regulatory strategy to commercialisation.
Our in-depth technical, clinical, regulatory and commercial expertise and highest European standards ensure the quality of our products. Highly efficient structures in our development and manufacturing processes enable us to quickly progress on our way to market.